The transport of L-arginine via hCAT-1 is increased by insulin [9], tumour growth factor ß1 (TGF-ß1) [14] and elevated extracellular D-glucose [6], and is reduced in diseases of pregnancy altering fetal growth such as intrauterine growth restriction (IUGR) [15]. Here, INS is linked to fetal growth restriction.